DoctorYourself.com - Cancer and Vitamin C References

Cancer Bibliography: Ewan Cameron, M.D. and Vitamin C Therapy

Cancer References
Home

REFERENCES to Dr. Cameron's Protocol for the Use of Intravenous Vitamin C in the Treatment of Cancer, posted in its entirety on this website at http://www.doctoryourself.com/cameron.html

1. Cameron, E. and Pauling, L. (1976) Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proceedings of the National Academy of Sciences USA. 73:3685-3689.

2. Cameron, E. and Pauling, L. (1978) Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. Proceedings of the National Academy of Sciences USA. 75:4538-4542

3. Morishige, F. and Murata, A. (1979) Prolongation of survival times in terminal human cancer by administration of supplemental ascorbate. Journal of the International Academy of Preventive Medicine. 5:47-52

4. Murata, A., Morishige, F. and Yamaguchi, H. (1982) Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. International Journal of Vitamin and Nutrition Research Suppl., 23, 1982, p. 103-113. Also in Hanck, A., ed. (1982) Vitamin C: New Clinical Applications. Bern: Huber, 103-113.

5. Rather D. CBS Network News; January 20, 1985.

6. Cameron, E. and Pauling, L. (1974) The orthomolecular treatment of cancer. 1. The role of ascorbate in host resistance. Chemical-Biological Interactions. 9:273-283.

7. Cameron E, Pauling L, Leibovitz B. (1979) Ascorbic acid and cancer: a review. Cancer Research 39, 663-681.

8. Cameron E, Pauling L. Cancer and Vitamin C. Linus Pauling Institute of Science and Medicine, Menlo Park, Ca. (1979); (Weidenfeld and Nicholson, London 1980; Kyoritsu Shuppan KK, Tokyo 1981; Warner Books, New York 1981; Services Complet d'Editions, Quebec and Paris 1982).

9. Yonemoto RH, Chretien PB, Fehnoer TF. Enhanced lymphocyte blastogenesis by oral ascorbic acid. Proc Am Assn Cancer Res 1976; 17:288.

10. Anderson R. Ascorbic acid and immune functions: mechanisms of immunostimulation. In, Counsell JN, Hornig DH (eds), Vitamin C. London, Applied Science Publishers 1981: 249-272.

11. Panush RS, Delafluente JC, Katz P, Johnson J. Modulation of certain immunologic responses by vitamin C. Ill. Potentiation of in vitro and in vivo lymphocyte responses. Int J Vitamin Nutr Res 1982; 23:35-37.

12. Siegel BV, Morton JI. Vitamin C and the immune response. Experimentia 1977; 33:393-395.

13. Siegel BV, Leibovitz B. The multifactorial role of vitamin C in health and disease. Int J Vitamin Nutr Res 1982; 23:9-22.

14. Benade L, Howard T, Burk D. Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4-triazole. Oncology 1969; 23:33-43.

15. Yamafuji K, Nakamura Y, Omura H, Soeda T, Gyotoku K. Anti-tumor potency of ascorbic, dehydroascorbic, or 2,3-diketogulonic acid and their action on deoxyribonucleic acid. Z Krebsforsch 1971; 76:1-7.

16. Yagashita K, Takahashi N, Yamamoto H, Jinnouchi H, Hiyoshi S, Miyakawa T. Effects of tetraacetyl-bis-dehydroascorbic acid, a derivative of ascorbic acid, on Ehrlich cells and HeLa cells (human carcinoma cells). J Nut Sci Vitaminol 1976; 22:419-427.

17. Cameron, E. and Campbell, A. (1974) The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic supplements in advanced human cancer. Chemical-Biological Interactions 9:285-315.

18. Cameron E, Campbell A, Jack T. The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact 1975; 11:387-393.

19. Creagan FT, Moertel CG, O'FalIon JR et al. Failure of high-dose vitamin C (ascorbic acid) to benefit patients with advanced cancer: a controlled trial. N Eng J Med 1979; 301:687-690.

20. Moertel CG, Fleming TR, Creagan FT et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. N Eng J Med 1985; 312:137-141.

21. Pauling, L (1980) Vitamin C therapy of advanced cancer (letter). New Eng. J. Med. 302, 694-695 (1980).

22. Cameron E. Vitamin C for cancer (letter). N Eng J Med 1980; 302:299.

23. Koch CJ, Biaglow JE. Toxicity, radiation sensitivity modification, and metabolic effects of dehydroascorbate and ascorbate in mammalian cells. J Cell Physiol 1978; 94:299-306.

24. Veltri RW, Maxim PE, Baseler MW, Cameransi BG, Kinger MR. L-ascorbic acid (vitamin C) augmentation of anticancer activity of methoxy-substituted benzoquinones, adriamycin and a dihydroxylated amino substituted quinone (DHAQ). (Submitted 1987 to Cancer Research)

25. Meredith P. (Linus Pauling Institute of Science and Medicine) Unpublished observations, 1983.

26. Cameron E, Moffat L, Campbell A, Marcuson R. Supplemental ascorbate in incurable cancer: an epidemiological study. (Submitted 1984 to N Eng J Med)

27. Campbell A, Jack T. Acute reactions to mega ascorbic acid therapy in malignant disease. Scott Med J 1979; 24:151-153.

28. Burke M. My successful fight against cancer: Burke, The Malt House, Warwick, 1982.

29. Hughes RE. Recommended daily amounts and biochemical roles - the vitamin C, carnitine, fatigue relationship. In Counsell JN, Hornig DH (eds), Vitamin C. Applied Science publishers, London 1982: 75-86.

30. Cameron E. Vitamin C and cancer cachexia: the carnitine connection. In Huemer RP (ed), The Roots of MolecuIar Medicine: A Tribute to Linus Pauling. W.H. Freeman and Co., New York 1986: 133-139.

31. Cameron E. Vitamin C, carnitine and cancer, or "My God. I Feel So Much Better, Doctor!" In Bland JS (ed), 1986: A Year in Nutritional Medicine. Keats Publishing Inc.) New Canaan) Connecticut 1986: 115-123.

32. Cameron, E. and Baird, G. (1973) Ascorbic acid and dependence on opiates in patients with advanced and disseminated cancer. Journal of International Research Communications. 1:38, August.

33. Basu TK, Raven RW, Dickerson JWT, Williams DC. Leucocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast cancer with skeletal metastases. Eur J Cancer, 1974; 10:507-511.

34. Lamden MP, Chrystowski GA. Urinary oxalate excretion by man following ascorbic acid ingestion. Proc Soc Exp Biol Med 1954; 85:190-198.

35. Fituri N, Allawi N, Bentley M, Costello J. Urinary and plasma oxalate during ingestion of pure ascorbic acid: a reevaluation. Eur UroI 1983; 9:312-315.

36. Tsao CS. Ascorbic acid and urinary oxalate (letter). Ann Int Med 1984; 101:405.

37. Tsao CS, Salimi SL. Effect of large intake of ascorbic acid on urinary and plasma oxalic acid levels. Int J Vitamin Nutr Res 1984; 54:245-249.

38. Hoffer A. Vitamin C and infertility (letter). Lancet 1973; ii:1146.

Additional References (Although listed by Dr. Cameron at the end of his Protocol for the use of Intravenous Vitamin C in the Treatment of Cancer, the following were not cited in the paper itself.)

Cameron E. Hyaluronidase and Cancer. Pergamon Press, Oxford, London and New York. 1966.

Cameron F, Rotman D. Ascorbic acid, cell proliferation and cancer (letter). Lancet 1972; i :542.

Cameron, E. and Pauling, L. (1973) Ascorbic acid and the glycosaminoglycans: An orthomolecular approach to cancer and other diseases. Oncology (Basel) 27: 181-192.

Cameron E. Vitamin C (letter). Brit J Hosp Med 1975; 13:511.

Cameron E. Biological function of ascorbic acid and the pathogenesis of scurvy. Medical Hypothesis, 1976; 2:154-163.

Cameron E, Pauling L. Experimental studies designed to evaluate the management of patients with incurable cancer. Proc Natl Acad Sci USA 1978; 75:6252.

Cameron E, Pauling L. (1979) Ascorbate and cancer. Proc. Am. Phil. Soc. 123:117-123.

Cameron E, Pauling L (1978) Ascorbic acid as a therapeutic agent in cancer. J. Intern. Acad. Prev. Med. 5 (1), 8-29

Cameron F, Pauling L. (1981) Survival times of terminal lung cancer patients treated with ascorbate. J. Intern. Acad. Prev. Med. 6: 21-27.

Cameron, Ewan (1982) Vitamin C and cancer: an overview. International Journal of Vitamin and Nutrition Research Suppl. 23.

Cameron F. Vitamin C and cancer: an overview. In Hanck A (ed). Vitamin C. New Clinical Applications. Huber; Bern, Stuttgart and Vienna 1982, p115-127.

Moffat L, Cameron E, Campbell A. High dose ascorbate therapy and cancer. In McBrien DCH, Slater TF (eds), Protective Agents in Cancer. Academic Press, London and New York 1983:243-256.

In addition to Dr. Cameron’s selected references listed above, see also:
Cameron E and Pauling L (1978) Ascorbic acid as a therapeutic agent in cancer. J. Intern. Acad. Prev. Med. 5 (1), 8-29.

Cameron E and Pauling L (1980) On cancer and vitamin C. Executive Health 16 (4), 1-8. Jan.

Cameron E and Pauling L (1981) Survival times of terminal lung cancer patients treated with ascorbate. J. Intern. Acad. Prev. Med. 6) 21-27.

Cameron E and Pauling L (1982) Megadoses of vitamin C as an adjunct in the treatment of cancer. Your Patient and Cancer 2, 39-46. May.

Pauling L and Cameron E (1983) Vitamin C and cancer. Australasian Health & Healing 2 (3), 9-10 (April-June).

Cameron, Ewan (Undated, c.1986-88) Protocol for the use of intravenous vitamin C in the treatment of cancer. Linus Pauling Institute of Science and Medicine, Palo Alto, California. 8 pp.

Cameron E and Pauling L (1987) Vitamin C and AIDS. Washington Post Health, p. 4. Feb. 3.

Cameron, E. (1991) Protocol for the use of vitamin C in the treatment of cancer. Medical Hypotheses. 36:190-194.

Cameron, E. and Campbell, A. (1991) Innovation vs. quality control: an "unpublishable" clinical trial of supplemental ascorbate in incurable cancer. Medical Hypotheses, 36(3), p 185-189, November.

Cameron, E. and Pauling, L. (1993) Cancer and Vitamin C, revised edition. Philadelphia: Camino Books.

Andrew Saul is the author of the books FIRE YOUR DOCTOR! How to be Independently Healthy (reader reviews at http://www.doctoryourself.com/review.html ) and DOCTOR YOURSELF: Natural Healing that Works. (reviewed at http://www.doctoryourself.com/saulbooks.html )

For ordering information, Click Here .

Andrew W. Saul

AN IMPORTANT NOTE: This page is not in any way offered as prescription, diagnosis nor treatment for any disease, illness, infirmity or physical condition. Any form of self-treatment or alternative health program necessarily must involve an individual's acceptance of some risk, and no one should assume otherwise. Persons needing medical care should obtain it from a physician. Consult your doctor before making any health decision.

Neither the author nor the webmaster has authorized the use of their names or the use of any material contained within in connection with the sale, promotion or advertising of any product or apparatus. Single-copy reproduction for individual, non-commercial use is permitted providing no alterations of content are made, and credit is given.